Leptin: The missing link in Alzheimer disease?

Clinical Chemistry

Volumn 56, Issue 5, 2010, Pages 696-697

  Harvey, Jenni ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; LEPTIN; OXIDOPAMINE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; BODY FAT; CONCENTRATION (PARAMETERS); FAT CONTENT; HIPPOCAMPUS; NERVE CELL PLASTICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RISK FACTOR; SHORT SURVEY; SYNAPTIC TRANSMISSION; WAIST HIP RATIO;

ALZHEIMER DISEASE; ANIMALS; HUMANS; INCIDENCE; LEPTIN; RISK FACTORS;

EID: 77951722495     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.144006     Document Type: Short Survey

References (5)

1. Harvey J. Leptin regulation of neuronal excitability and cognitive function. Curr Opin Pharmacol 2007;7:643-647 (Pubitemid 350177556)
2. O'Malley D, MacDonald N, Mizielinska S, Connolly CN, Irving AJ, Harvey J. Leptin promotes rapid dynamic changes in hippocampal dendritic morphology. Cell Mol Neurosci 2007;35:559-572 (Pubitemid 47193112)
3. Li XL, Aou S, Oomura Y, Hori N, Fukunaga K, Hori T. Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neurosci 2002;113:607-615 (Pubitemid 34874684)
4. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009;302:2565-2572
5. Dawber TR, Meadors GF, Moore FR Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951;41:279-281